PATENT CLAIM ANALYSIS

Application Number: 16379559
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["424", "009100"]

Abstract:
The present subject matter is directed to a method of manufacturing and purifying an intravenous injection of prothrombin complex concentration (PCC) from plasma Fraction III and a method of manufacturing and purifying an intravenous injection of non-PCC from plasma Fraction IV. The intravenous injection of PCC and non-PCC obtained from the method can be administered to a patient in need thereof for stopping replication, killing and preventing HIV-1 and HIV-2 in a patient.

Claim (Index 12):
A method of stopping replication of HIV-1 and HIV-2 in a patient comprising administering the intravenous injection of PCC obtained from the method of  claim 1  to a patient in need thereof.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 100.0
- Lexical Diversity: 1.69565
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15090033', '15278699', '14056363', '13633057', '12842944']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6995945914824258
- 35 USC 102 Novelty (BERT): 0.5445679693113862
- Combined Prediction Score: 0.6840919292653218
- Mean Citation Score: 220.655234
- Max Citation Score: 441.10236
- Similarity Product: 232.01538185862063

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test